dr. osborne on the benefits of dual-targeted therapy for her2 breast cancer
Published 7 years ago • 163 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:07
dr. osborne on evaluating her2-positivity in breast cancer
-
0:50
dr. osborne on pertuzumab in her2 breast cancer
-
2:20
dr. osborne discusses targeting the her2 pathway in breast cancer
-
1:02
dr. janni on the benefits of targeted therapies for her2 breast cancer
-
1:18
dr. osborne discusses the future of treatment in her2 breast cancer
-
31:35
c. kent osborne, m.d., on advances in therapy for her2 breast cancer
-
8:39
breast cancer: dual her2-targeted adjuvant therapy
-
1:20
dr. barrio on treatment options for her2 breast cancer
-
2:41
dr. bardia on dual targeting of the her2 receptor
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
7:44
hormonal and her2-targeted therapy in early breast cancer
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
1:16:56
navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:13
dr. hamilton on overcoming resistance to her2-targeted therapy in breast cancer
-
1:10
dr. janni on the future of treatments for her2-positive breast cancer
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy
-
1:22
dr. debu tripathy gives an overview of targeted therapies for breast cancer